1. Abumiya, T., Fitridge, R., Mazur, C., Copeland, B.R., Koziol, J.A., Tschopp, J.F., Pierschbacher, M.D., del Zoppo, G.J., and Hurn, P.D., Integrin α IIb β3 Inhibitor Preserves Microvascular Patency in Experimental Acute Focal Cerebral Ischemia, Stroke, 2000, vol. 31, pp. 1402–1410.
2. Ahmed, A.K., Warnock, M., Nieman, M., Srikanth, S., Mahdi, F., Krishnan, R., Tulinsky, A., and Schmaier, A.H., Mechanisms of Arg-Pro-Gly-Phe Inhibition of Thrombin, J. Physiol Heart Circ Physiol, 2003, vol. 285, pp. 183–193.
3. Ashmarin, I.P., Pastorova, V.E., Lyapina, L.A., Kudryashov, B.A., Kalikhevich, V.A., Kamenskii, A.A., and Azieva, L.D., The effect of Tuftsin on Fibrin Polymerization in Vitro and on the Hemostatic System When Administered Intravenously to Healthy Animals, Izv. Akad. Nauk SSSR. Ser. Biol., 1991, no. 2, pp. 302–308.
4. Ashmarin, I.P., Lyapina, L.A., and Pastorova, V.E., Modulation of Hemostatic Reactions in vitro and in vivo by Representatives of Control Peptide Families, Vestn. Ross. Akad. Med. Nauk, 1996, no. 6, pp. 50–58.
5. Ashmarin, I.P., Levitskaya, N.G., Kamenskii, A.A., and Myasoedov, N.F., Semax—A New Drug for Correcting Cerebral Circulation, Hypoxic States, and Increasing Mental Activity, Farmateka, 1997, no. 4, pp. 32–33.